ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 82 filers reported holding ARBUTUS BIOPHARMA CORP in Q4 2020. The put-call ratio across all filers is 1.54 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $140,776 | +10.3% | 69,348 | +24.9% | 0.00% | – |
| Q2 2023 | $127,673 | -41.4% | 55,510 | -22.9% | 0.00% | – |
| Q1 2023 | $218,030 | +86.2% | 71,957 | +43.2% | 0.00% | – |
| Q4 2022 | $117,108 | +24.6% | 50,261 | +1.5% | 0.00% | – |
| Q3 2022 | $94,000 | -39.0% | 49,541 | -12.7% | 0.00% | – |
| Q2 2022 | $154,000 | +18.5% | 56,758 | +30.3% | 0.00% | – |
| Q1 2022 | $130,000 | -31.6% | 43,554 | -10.8% | 0.00% | – |
| Q4 2021 | $190,000 | -4.0% | 48,800 | +5.6% | 0.00% | – |
| Q3 2021 | $198,000 | -82.6% | 46,216 | -87.7% | 0.00% | -100.0% |
| Q2 2021 | $1,138,000 | +550.3% | 375,753 | +614.8% | 0.00% | – |
| Q1 2021 | $175,000 | -56.2% | 52,567 | -58.9% | 0.00% | – |
| Q3 2020 | $400,000 | +9900.0% | 127,785 | +7235.5% | 0.00% | – |
| Q4 2019 | $4,000 | -81.8% | 1,742 | -88.2% | 0.00% | – |
| Q3 2019 | $22,000 | -85.3% | 14,812 | -79.7% | 0.00% | – |
| Q2 2019 | $150,000 | -67.9% | 73,007 | -44.3% | 0.00% | – |
| Q1 2019 | $468,000 | -6.6% | 131,154 | +0.0% | 0.00% | – |
| Q4 2018 | $501,000 | -82.8% | 131,134 | -57.4% | 0.00% | -100.0% |
| Q3 2018 | $2,908,000 | +108.0% | 307,893 | +60.6% | 0.00% | – |
| Q2 2018 | $1,398,000 | +331.5% | 191,743 | +195.4% | 0.00% | – |
| Q1 2018 | $324,000 | -60.7% | 64,913 | -60.3% | 0.00% | -100.0% |
| Q4 2017 | $825,000 | +1.7% | 163,451 | +24.8% | 0.00% | 0.0% |
| Q3 2017 | $811,000 | +24.2% | 131,000 | -28.0% | 0.00% | – |
| Q2 2017 | $653,000 | +49.8% | 181,938 | +35.1% | 0.00% | – |
| Q1 2017 | $436,000 | +99.1% | 134,705 | +50.2% | 0.00% | – |
| Q4 2016 | $219,000 | -68.3% | 89,679 | -55.4% | 0.00% | – |
| Q3 2016 | $690,000 | +6.2% | 201,210 | +7.6% | 0.00% | – |
| Q2 2016 | $650,000 | +81.6% | 186,993 | +114.8% | 0.00% | – |
| Q1 2016 | $358,000 | -56.1% | 87,073 | -52.6% | 0.00% | -100.0% |
| Q4 2015 | $816,000 | -12.0% | 183,514 | +20.4% | 0.00% | 0.0% |
| Q3 2015 | $927,000 | – | 152,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 340,000 | $1,459,000 | 0.53% |
| RTW INVESTMENTS, LP | 4,733,323 | $20,306,000 | 0.31% |
| APIS CAPITAL ADVISORS, LLC | 70,000 | $300,000 | 0.29% |
| Hudson Bay Capital Management LP | 1,800,000 | $7,722,000 | 0.10% |
| COWEN AND COMPANY, LLC | 249,215 | $1,069,000 | 0.05% |
| Kerrisdale Advisers, LLC | 100,000 | $429,000 | 0.05% |
| Woodline Partners LP | 496,172 | $2,129,000 | 0.04% |
| Shay Capital LLC | 60,000 | $257,000 | 0.03% |
| Walleye Capital LLC | 231,037 | $991,000 | 0.03% |
| BOOTHBAY FUND MANAGEMENT, LLC | 212,700 | $912,000 | 0.02% |